Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 15 studies | 66% ± 19% | |
| oligodendrocyte precursor cell | 9 studies | 34% ± 18% | |
| plasmacytoid dendritic cell | 8 studies | 29% ± 9% | |
| endothelial cell | 7 studies | 21% ± 6% | |
| astrocyte | 5 studies | 30% ± 17% | |
| kidney loop of Henle epithelial cell | 4 studies | 18% ± 3% | |
| fibroblast | 4 studies | 23% ± 6% | |
| neuron | 3 studies | 32% ± 8% | |
| epithelial cell | 3 studies | 37% ± 6% | |
| ciliated cell | 3 studies | 22% ± 2% | |
| Mueller cell | 3 studies | 23% ± 6% | |
| GABAergic neuron | 3 studies | 17% ± 2% | |
| dendritic cell | 3 studies | 24% ± 5% | |
| glial cell | 3 studies | 42% ± 28% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 36507.27 | 2642 / 2642 | 100% | 299.62 | 705 / 705 |
| prostate | 100% | 5856.13 | 244 / 245 | 100% | 76.07 | 501 / 502 |
| bladder | 100% | 4962.00 | 21 / 21 | 98% | 50.07 | 493 / 504 |
| esophagus | 100% | 6515.87 | 1442 / 1445 | 97% | 37.17 | 178 / 183 |
| skin | 97% | 4605.09 | 1757 / 1809 | 100% | 164.91 | 471 / 472 |
| uterus | 96% | 4356.84 | 163 / 170 | 100% | 63.39 | 457 / 459 |
| breast | 96% | 4189.85 | 441 / 459 | 99% | 55.99 | 1103 / 1118 |
| thymus | 92% | 3577.47 | 602 / 653 | 99% | 49.39 | 601 / 605 |
| intestine | 93% | 5782.84 | 902 / 966 | 98% | 36.33 | 514 / 527 |
| ovary | 91% | 4183.51 | 164 / 180 | 96% | 34.54 | 414 / 430 |
| adrenal gland | 97% | 4281.42 | 250 / 258 | 89% | 30.23 | 205 / 230 |
| kidney | 85% | 4699.83 | 76 / 89 | 94% | 48.74 | 844 / 901 |
| lung | 73% | 2629.62 | 423 / 578 | 98% | 47.32 | 1133 / 1155 |
| liver | 72% | 2501.19 | 163 / 226 | 97% | 36.80 | 393 / 406 |
| stomach | 60% | 2735.20 | 217 / 359 | 95% | 35.07 | 271 / 286 |
| pancreas | 34% | 1047.95 | 111 / 328 | 99% | 46.89 | 176 / 178 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 64.24 | 29 / 29 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 57.79 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 35.23 | 1 / 1 |
| eye | 0% | 0 | 0 / 0 | 99% | 67.64 | 79 / 80 |
| adipose | 96% | 4350.06 | 1154 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 93% | 3363.02 | 224 / 241 | 0% | 0 | 0 / 0 |
| blood vessel | 89% | 3476.28 | 1185 / 1335 | 0% | 0 | 0 / 0 |
| heart | 39% | 1221.50 | 335 / 861 | 0% | 0 | 0 / 0 |
| muscle | 25% | 719.08 | 201 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 25% | 1024.63 | 232 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0030900 | Biological process | forebrain development |
| GO_0008344 | Biological process | adult locomotory behavior |
| GO_0007409 | Biological process | axonogenesis |
| GO_0009214 | Biological process | cyclic nucleotide catabolic process |
| GO_0007268 | Biological process | chemical synaptic transmission |
| GO_0048709 | Biological process | oligodendrocyte differentiation |
| GO_0021762 | Biological process | substantia nigra development |
| GO_0046902 | Biological process | regulation of mitochondrial membrane permeability |
| GO_0009636 | Biological process | response to toxic substance |
| GO_0032496 | Biological process | response to lipopolysaccharide |
| GO_0005902 | Cellular component | microvillus |
| GO_0005615 | Cellular component | extracellular space |
| GO_0048471 | Cellular component | perinuclear region of cytoplasm |
| GO_0016020 | Cellular component | membrane |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005743 | Cellular component | mitochondrial inner membrane |
| GO_0045202 | Cellular component | synapse |
| GO_0035748 | Cellular component | myelin sheath abaxonal region |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0031143 | Cellular component | pseudopodium |
| GO_0005741 | Cellular component | mitochondrial outer membrane |
| GO_0042470 | Cellular component | melanosome |
| GO_0035749 | Cellular component | myelin sheath adaxonal region |
| GO_0003723 | Molecular function | RNA binding |
| GO_0004113 | Molecular function | 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity |
| GO_0030551 | Molecular function | cyclic nucleotide binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | CNP |
| Protein name | 2',3'-cyclic-nucleotide 3'-phosphodiesterase (CNP) (CNPase) (EC 3.1.4.37) 2',3'-cyclic nucleotide 3' phosphodiesterase |
| Synonyms | |
| Description | FUNCTION: Catalyzes the formation of 2'-nucleotide products from 2',3'-cyclic substrates (By similarity). May participate in RNA metabolism in the myelinating cell, CNP is the third most abundant protein in central nervous system myelin (By similarity). . |
| Accessions | ENST00000587679.1 P09543 ENST00000393892.8 [P09543-1] K7EN66 K7EQ27 ENST00000589772.1 ENST00000393888.1 [P09543-2] ENST00000441615.2 C9K0L8 ENST00000472031.1 K7ERC4 K7ERZ0 ENST00000585452.1 |